Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy.
about
The impact of DMARD and anti-TNF therapy on functional characterization of short-term T-cell activation in patients with rheumatoid arthritis--a follow-up study.Calcium Influx Characteristics During T Lymphocyte Activation Measured with Flow Cytometry.Increase risk of allergic diseases in patients with ankylosing spondylitis: A 10-year follow-up population-based study in Taiwan.Epigenetic and gene expression analysis of ankylosing spondylitis-associated loci implicate immune cells and the gut in the disease pathogenesis.Protective effect of allograft inflammatory factor-1 on the apoptosis of fibroblast-like synoviocytes in patients with rheumatic arthritis induced by nitro oxide donor sodium nitroprusside.T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis.The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis.Effects of TNF-alpha inhibitors on circulating Th17 cells in patients affected by severe psoriasis.The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis.Progress of genome-wide association studies of ankylosing spondylitis.
P2860
Q34011119-E1EF93C5-D7FE-46EF-94F8-FACCEE097A96Q37155347-D89208AD-CFE4-4F87-AA29-14F7A3ADDC24Q37409527-0738E2B7-DF58-4736-80EE-78EF26A33FEAQ38432390-E7F75F61-DC16-4370-A333-149E36040BA9Q40252578-DC698DE8-579E-4FB0-81DB-1FD90DC52183Q43043328-0830BEB7-0768-491B-86D7-F130E105EFE5Q45418268-33E1E0BB-BB68-4B42-B30E-BED0BE239C6AQ46439316-808455A9-327D-4636-8825-70720F29D347Q46643381-53A254FD-2D70-41CB-B62D-4D12A2C538A8Q47357132-0C9F92A9-FCD0-4233-A20F-1D74C08AE601Q49871790-46BD727F-FE77-41B6-9ADE-CA8F12E33999
P2860
Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Adaptive immunity in ankylosin ...... and during infliximab therapy.
@ast
Adaptive immunity in ankylosin ...... and during infliximab therapy.
@en
type
label
Adaptive immunity in ankylosin ...... and during infliximab therapy.
@ast
Adaptive immunity in ankylosin ...... and during infliximab therapy.
@en
prefLabel
Adaptive immunity in ankylosin ...... and during infliximab therapy.
@ast
Adaptive immunity in ankylosin ...... and during infliximab therapy.
@en
P2093
P2860
P50
P356
P1476
Adaptive immunity in ankylosin ...... and during infliximab therapy
@en
P2093
Attila Balog
Barna Vásárhelyi
László Kovács
Magdolna Deák
P2860
P304
P356
10.1155/2012/808724
P577
2011-09-28T00:00:00Z